Tianwei is a practitioner of patient innovation. But before, he was an investor scouting early-stage drug asset. His career trajectory was particularly influenced by his father, a liver transplant patient who has survived for 20 years.

In the process of interacting with patients, pharmaceutical companies, and medical systems , Tianwei clearly felt that the current medical system is elite-centered rather than patient-centered.

Interestingly, during his days and nights with patients and patient communities, he also clearly saw how patients became innovators and solved problems that were not seen by producers and academians.

In order to promote patient innovation in the academic world, Tianwei is going to study the phenomenon of patient innovation at the Chinese University of Hong Kong, meanwhile exploring the development of lead user(patient) theory with scholars from MIT and Tsinghua University.

Besides his academic pursuit, he is still actively working as a community member to find and cultivate patient-driven innovations with different patient innovaors across China.

He has a dream, that one day, patient innovation will not only revolutionlize the current medical innovation framework, but also bring true patient-centricity by incoporating patient innovation into medical educaiton.